Evidence map›Paper›PMID 30032141›Full record

ArticleGerontology2019

The Better Assessment of Illness Study for Delirium Severity: Study Design, Procedures, and Cohort Description.

Tammy T Hshieh, Tamara G Fong, Eva M Schmitt, Edward R Marcantonio, Madeline L D'Aquila, Jacqueline Gallagher, Guoquan Xu, Yun R Guo, Tatiana F Abrantes, Sylvie E Bertrand and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Gerontology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Domains of delirium severity in Alzheimer's disease and related dementias.Journal of the American Geriatrics Society · 2022
    Article
  4. Harmonization of Four Delirium Instruments: Creating Crosswalks and the Delirium Item-Bank (DEL-IB).The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Use of an expert panel to identify domains and indicators of delirium severity.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Tammy T HshiehAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USAthshieh@bwh.harvard.edu.
Tamara G FongAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Eva M SchmittAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Edward R MarcantonioDepartment of Medicine, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Madeline L D'AquilaAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Jacqueline GallagherDepartment of Medicine, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Guoquan XuAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Yun R GuoAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Tatiana F AbrantesAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Sylvie E BertrandAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Richard N JonesDepartment of Psychiatry and Human Behavior, Department of Neurology, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
Sharon K InouyeAging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
for the BASIL Study Group
Hebrew SeniorLife · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USBrown University · US

Funding

The Role of Inflammation in the Pathophysiology of Delirium and its Associated Long-Term Cognitive DeclineP01AG031720 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K. · 2010 to 2022
$26.7M
READI-SET-GO: Researching Efficient Approaches to Delirium Identification - Sustaining Effective Translation to create Gero-friendly OrganizationsR01AG030618 · NIA · PENNSYLVANIA STATE UNIVERSITY, THE · PI DONNA Marie FICK, EDWARD R MARCANTONIO · 2008 to 2026
$7.9M
Development and Validation of a Delirium Severity ToolkitR01AG044518 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K., JONES, RICHARD N · 2014 to 2024
$7.3M
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-OmicsR01AG051658 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TOWIA A. LIBERMANN, EDWARD R MARCANTONIO · 2016 to 2026
$5.9M
Supplement to Network for Investigation of Delirium across the U.S (NIDUS)R24AG054259 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K. · 2016 to 2020
$4.3M
Mid-Career Mentoring Award for Patient-Oriented Research in AgingK24AG035075 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MARCANTONIO, EDWARD R · 2010 to 2021
$1.9M
K07 Leadership GrantK07AG041835 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K. · 2013 to 2017
$656k
Blood-based biomarkers of neuronal injury and Alzheimer's disease: predictors of delirium and long-term cognitive decline, and potential shared pathophysiologyR21AG057955 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI FONG, TAMARA G · 2017 to 2018
$471k
NIA NIH HHS K07 AG041835NIA NIH HHS K24 AG035075NIA NIH HHS P01 AG031720NIA NIH HHS R01 AG030618NIA NIH HHS R01 AG044518NIA NIH HHS R01 AG051658NIA NIH HHS R21 AG057955NIA NIH HHS R24 AG054259
6 · The paper itself

Abstract

BACKGROUND/

objectivesTo describe the design, procedures, and cohort for the Better ASsessment of ILlness -(BASIL) study, which is conducted to develop and test new delirium severity measures, compare them with existing measures, and examine related clinical outcomes.

methodsProspective cohort study with 1 year follow-up of study participants at a large teaching hospital in Boston, Massachusetts. After brief cognitive testing and the Delirium Symptom Interview, delirium and delirium severity were rated daily in the hospital using the Confusion Assessment Method (CAM) and CAM-Severity score, the Delirium Rating Scale-Revised-98 (DRS-R-98), and the Memorial Delirium Assessment Scale (MDAS). Other key study variables included comorbidity, physical function (basic and instrumental activities of daily living [ADL]), ratings of subjective health and well-being, and clinical outcomes (length of stay, 30 day rehospitalization, nursing home admission, healthcare utilization). Follow-up interviews occurred at 1- and 12-month with patients and families. In 42 patient interviews, inter-rater reliability for key variables was assessed.

resultsOf 768 eligible patients approached, 469 were screened and 352 enrolled, yielding an overall study response rate of 67% for potentially eligible participants. The mean participant was 80.3 years old (SD 6.8) and 203 (58%) were female. The majority of patients were medically complex with Charlson Comorbidity Scores ≥2 (192 patients, 55%), and 102 (29%) met criteria for dementia. Inter-rater reliability assessments (n = 42 pairs) were high for overall ratings of presence or absence of delirium by CAM (κ = 1.0), delirium severity by DRS-R-98 and MDAS (weighted kappa, κ = 1.0 for each) and for ADL impairment (κ = 1.0). For eligible participants at each time point, 278 out of 308 (90%) completed the 1-month follow-up and 132 out of 256 (53%) have completed the 12-month follow-up to date, which is still in progress. Among those who completed interviews, there was only 1-3% missing data on most major outcomes (delirium, basic ADL, and readmission).

conclusionThe BASIL study presents an innovative effort to advance the conceptualization and measurement of delirium severity. Unique strengths include the diverse cohort with complete high quality data and longitudinal follow-up, along with detailed collection of multiple delirium measures daily during hospitalization.

Indexed as

DeliriumHospitalizationNeuropsychological TestsPhysical Functional PerformanceActivities of Daily LivingAgedAged, 80 and overCognitionComorbidityEligibility DeterminationFemaleGeriatric AssessmentHumansMaleOutcome Assessment, Health CareResearch DesignCohort descriptionData qualityDeliriumDelirium severity ratingMethodsStudy design

Identifiers

PMID30032141
PMCPMC6335161
OpenAlexW2885395963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.